Sensus Healthcare (SRTS) Stock Price, News & Analysis

Company Overview

Sensus Healthcare, Inc. is a medical technology company specializing in the design, development and commercialization of superficial radiotherapy systems for the treatment of non-melanoma skin cancers and keloids. Its flagship products, the SRT-100 and SRT-100+ systems, deliver low-energy X-ray therapy in a non-invasive, outpatient setting, providing clinicians with an alternative to surgery and enabling patients to preserve cosmetic appearance and minimize recovery time.

The company’s product portfolio includes the SRT-100 series systems, handpieces and applicators tailored to various lesion sizes and anatomical locations. These systems employ targeted superficial radiation to deliver precise doses to the treatment site while sparing surrounding healthy tissue. Sensus Healthcare also offers comprehensive service, training and maintenance programs designed to support clinic staff and ensure consistent, high-quality patient care.

Founded in the late 1990s and headquartered in Orlando, Florida, Sensus Healthcare has expanded its presence across the United States and into select international markets. The company’s direct sales organization serves dermatology, oncology and plastic surgery practices, while strategic partnerships and distribution agreements facilitate access in Europe, Latin America and the Middle East. Ongoing research and development efforts focus on enhancing device functionality, streamlining clinical workflows and exploring new therapeutic applications.

Under the leadership of Chief Executive Officer José Báez, the company prioritizes regulatory compliance, quality assurance and evidence-based clinical data. Sensus Healthcare’s executive team and board of directors bring extensive experience in medical device innovation, commercial strategy and healthcare operations. Through collaboration with key opinion leaders and professional societies, the company continues to advance the adoption of superficial radiotherapy as a standard of care in dermatologic oncology.

Key Stats

• Today's Range: $4.15 to $4.39
• 50-Day Range: $4.07 to $5.13
• 52-Week Range: $4.01 to $9.33
• Volume: 131,034 shs
• Average Volume: 189,719 shs
• Market Capitalization: $71.02 million
• P/E Ratio: 43.20
• Dividend Yield: N/A
• Price Target: $11.67
• Consensus Rating: Buy

Sensus Healthcare Stock Analysis - MarketRank™

Sensus Healthcare scored higher than 22% of companies evaluated by MarketBeat, and ranked 856th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Sensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sensus Healthcare has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -28.13%

Earnings Growth

Earnings for Sensus Healthcare are expected to decrease by -28.13% in the coming year, from $0.32 to $0.23 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sensus Healthcare is 43.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.26.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sensus Healthcare is 43.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.69.

Price to Book Value per Share Ratio

Sensus Healthcare has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.33% of the float of Sensus Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Sensus Healthcare has a short interest ratio ("days to cover") of 10.2, which indicates bearish sentiment.

Change versus previous month

Short interest in Sensus Healthcare has recently increased by 2.37%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sensus Healthcare does not currently pay a dividend.

Dividend Growth

Sensus Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

6.33% of the float of Sensus Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Sensus Healthcare has a short interest ratio ("days to cover") of 10.2, which indicates bearish sentiment.

Change versus previous month

Short interest in Sensus Healthcare has recently increased by 2.37%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.94

News Sentiment

Sensus Healthcare has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sensus Healthcare this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sensus Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.90% of the stock of Sensus Healthcare is held by insiders.

Percentage Held by Institutions

Only 25.30% of the stock of Sensus Healthcare is held by institutions.

SRTS Stock Analysis - Frequently Asked Questions

How have SRTS shares performed this year?

Sensus Healthcare's stock was trading at $6.92 at the beginning of 2025. Since then, SRTS stock has decreased by 37.6% and is now trading at $4.32.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) released its earnings results on Thursday, May, 15th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.20. The company earned $8.34 million during the quarter, compared to analysts' expectations of $7.23 million. Sensus Healthcare had a trailing twelve-month return on equity of 3.34% and a net margin of 4.56%.
Read the conference call transcript.

When did Sensus Healthcare IPO?

Sensus Healthcare (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Who are Sensus Healthcare's major shareholders?

Sensus Healthcare's top institutional shareholders include Kingstone Capital Partners Texas LLC (4.07%), Chapin Davis Inc. (0.15%) and Wealth Enhancement Advisory Services LLC (0.07%). Insiders that own company stock include Joseph C Sardano, Samuel O'rear, John Heinrich and Michael Sardano.
View institutional ownership trends.

How do I buy shares of Sensus Healthcare?

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CrowdStrike (CRWD), EMCOR Group (EME), e.l.f. Beauty (ELF) and Arista Networks (ANET).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SRTS
• CIK: 1494891
• Web: www.sensushealthcare.com
• Phone: (561) 922-5808
• Fax: 561-948-2071
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Sensus Healthcare: $11.67
• High Price Target: $13.00
• Low Price Target: $10.00
• Potential Upside/Downside: +168.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.10
• Trailing P/E Ratio: 43.35
• Forward P/E Ratio: 13.60
• P/E Growth: N/A
• Net Income: $6.65 million
• Net Margins: 4.56%
• Pretax Margin: 8.76%
• Return on Equity: 3.34%
• Return on Assets: 3.00%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.06
• Quick Ratio: 5.74

Sales & Book Value

• Annual Sales: $41.81 million
• Price / Sales: 1.71
• Cash Flow: $0.45 per share
• Price / Cash Flow: 9.63
• Book Value: $3.41 per share
• Price / Book: 1.28

Miscellaneous

• Outstanding Shares: 16,440,000
• Free Float: 14,981,000
• Market Cap: $71.56 million
• Optionable: Optionable
• Beta: 1.29